Unlocking 5-MeO-DMT: New Paths for Mental Health

Psychedelic substances like LSD and psilocybin show promise in treating neuropsychiatric disorders. These drugs typically interact with serotonin receptors, specifically 5-HT2A and 5-HT1A. This study explores how the lesser-known psychedelic, 5-MeO-DMT, interacts with these receptors to understand its potential therapeutic benefits.